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Abstract Objective Endometriosis is a complex disease, and pain is an important component of the
syndrome. One of the most used methods to assess pain is the visual analogue scale (VAS).
Theaimof thepresent researchwas to studythepainexperiencedbypatientswhoreferred to
our unit for endometriosis, using the VAS to understand the variables that could inﬂuence it.
Methods We have conducted a prospective study from February 2012 to Decem-
ber 2016, enrolling 388 patients who referred to a university hospital, in Florence, Italy.
We have included in the present study patients during their follow-up for endometri-
osis; we have also included patients who underwent surgery with a histological
diagnosis of endometriosis. We have collected sociodemographic and clinical informa-
tion regarding age, bodymass index (BMI), smoking habit, number of pregnancies, and
endometriosis staging. Finally, we have administered the VAS for several symptoms.
Results Dysmenorrhea was the symptom associated with the highest perception of pain
(mean VAS score of 5.76). The logistic regression showed that the stage of endometriosis
could inﬂuence the pain associated to constipation and to dysuria. The linear regression
showed that age could inﬂuence the pain associated to constipation, to dyspareunia, and to
dysmenorrhea. A positive correlation was found between dysmenorrhea and chronic pelvic
pain(CPP),betweendysmenorrheaanddyspareunia,andbetweenconstipationanddysuria.
Conclusion Using a validatedmethod, the VAS, we have studied the pain experienced
by a group of patients with a history of endometriosis and observed that smoking habit
and BMI did not inﬂuence the VAS scores, and that dysmenorrhea was associated with
the highest perception of pain.
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Introduction
Endometriosis could be deﬁned as the presence of endome-
trial-type mucosa outside the uterine cavity, and its standard
diagnosis is performed through a direct visualization and
histological examination of the lesions.1 Endometriosis has
been estimated to affect up to between 10 and 15% of women
of reproductive age.2 The prevalence of endometriosis
increases dramatically to as high as between 25–50% in
women with infertility, and between 30–50% of the women
with endometriosis have infertility.3 One of the main symp-
toms of endometriosis is pain. Classically, there are three
types of pain related to endometriosis: dysmenorrhea, deep
dyspareunia, and non-menstrual chronic pelvic pain (CPP).4
Women with endometriosis may also experience a wide
variety of other symptoms, including dyschezia, dysuria,
gastrointestinal complaints, rectal bleeding with signiﬁcant
bowel involvement, menstrual dysfunction such as oligome-
norrhea or hypermenorrhea, low back pain, and infertility.5–7
The pain usually begins 1 or 2 days before the expected onset
of menstruation, may be unilateral or bilateral, and lasts until
the end of menses. However, some women may experience a
constant, debilitating pain that interferes with their daily
lives.8
In particular, CPP causes neurological changes in the dorsal
horn of the spine, resulting in neurogenic inﬂammation of
multiple pelvic viscera, hyperalgesia, dysreﬂexia, a lower
sensory threshold and, therefore, a greater perception of
pain. Endometriosis is observed in between 71–87% of the
women with CPP.9,10 A recently published review about pain
assessment in patients with endometriosis stated that the
visual analog scale (VAS)wasusedmost frequently,witha total
of 167 publications identiﬁed in this search.4 The VAS consists
of a 10-cm longhorizontal linewith its extremesmarkedas ‘no
pain’ and ‘worst pain imaginable’. Each patient ticks her pain
level on the line and thedistance from ‘nopain’on the extreme
left to the tickmark ismeasured in centimeters, yielding a pain
score from 0 to 10. This self-report of pain is considered as the
gold standard of pain measurement.11
The aim of the present research was to study the pain
experienced by a group of patients who referred to our unit
with a history of endometriosis. Our primary objectives
were: 1) to use the VAS, to measure the pain related to the
following symptoms: dyschezia, dysuria, chronic pelvic pain,
dyspareunia, and dysmenorrhea; 2) to use the VAS score to
evaluate the impact of age, body mass index (BMI), smoking
habit, and stage of the disease on pain; 3) to detect possible
correlations among the symptoms in terms of VAS scores.
Methods
Study Design
We have conducted a prospective study from February 2012
to December 2016, enrolling patients who referred to our
tertiary university hospital, in Florence.
The present study was approved and data were collected
in a totally anonymous way: the patients signed an informed
consent form for the clinical investigations and for the
disposition of the results for scientiﬁc analysis according
to privacy laws and to human rights before being enrolled.
Resumo Objetivo A endometriose é uma doença complexa, e a dor é um componente
importante da enfermidade. Um dos métodos mais utilizados para avaliar a dor é a
escala visual analógica (EVA). O objetivo da presente pesquisa foi estudar a dor sentida
pelas pacientes que se referiram à nossa unidade para endometriose, usando a EVA
para entender as variáveis que poderiam inﬂuenciá-la.
Métodos Realizamos um estudo transversal de fevereiro de 2012 a dezembro de 2016,
envolvendo 388 pacientes que se referiram a um hospital universitário, em Florença, Itália.
Incluímos nossos pacientes do estudo durante o acompanhamento da endometriose;
incluímos tambémpacientes que se submeteramà cirurgia comdiagnóstico histológico de
endometriose. Coletamos informações sociodemográﬁcas e clínicas sobre idade, índice de
massa corporal (IMC), hábito de fumar, número de gravidezes e estágio da endometriose.
Finalmente, administramos a EVA para vários sintomas.
Resultados A dismenorreia foi o sintoma associado à maior percepção de dor (média
do escore EVA de 5,76). A regressão logística mostrou que o estágio da endometriose
poderia inﬂuenciar a dor associada à constipação e à disúria. A regressão linear mostrou
que a idade poderia inﬂuenciar a dor associada à constipação, à dispareunia e à
dismenorreia. Uma correlação positiva foi encontrada entre dismenorreia e dor pélvica
crônica, entre dismenorreia e dispareunia, e entre constipação e disúria.
Conclusão Utilizando um método validado, a EVA, estudamos a dor sentida por um
grupo de pacientes com história de endometriose e observamos que o hábito de fumar
e o IMC não inﬂuenciaram os escores EVA, e que a dismenorreia foi associada à maior
percepção de dor.
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We have included in the present study patients during their
follow-up for endometriosis; we have also included patients
who underwent surgery with a histological diagnosis of endo-
metriosis. The histological diagnosis was performed by evaluat-
ing the presence of endometrial tissue outside the uterine
cavity, according to the current guidelines.12 In the studygroup,
the stage of endometriosis was determined using the medical
records of the patients, and it was classiﬁed according to the
deﬁnition of the American Society for Reproductive Medicine
(ASMR).13 Endometriosis is classiﬁed on the basis of number,
size, and superﬁcial and/or deep location of endometrial
implants,plaques, endometriomasand/oradhesions, as follows:
stage I (minimal, 1–5 points), stage II (mild, 6–15 points), stage
III (moderate, 16–40 points), and stage IV (severe, > 40 points).
Sociodemographic and clinical information regarding age,
BMI, smoking habit, and number of pregnancies were only
available when the study started; afterwards, we inter-
viewed the patients by administering the VAS: we have
used this score to describe the pain associated with dysche-
zia, dysuria, CPP, dyspareunia, and dysmenorrhea.
Statistical Analysis
Data were collected in a database and processed using the
software Stata 12 (StataCorp, College Station, TX, USA). The
Shapiro-Wilk test was used to assess the non-normal distribu-
tion of the examined variables. Although not normally distrib-
uted, we have calculated means, medians, and standard
deviations (SDs) for each variable.Wehave used logistic regres-
sion and the Spearman correlation test to analyze the relation-
ship between the independent variables (stage, age, smoking
habit, and BMI) and the VAS scores of each type of pain. A
multiple regressionwas used to understand a possible correla-
tion between the painwith the highest VAS score and the other
types of pain. The level of signiﬁcance was set at p < 0.05.
Results
We have collected information from 388 women: our sample
had a mean age of 36.65 years old (SD ¼ 8.99; median ¼ 37
yearsold; range17–58yearsold). ThemeanBMIwas22.5kg/m2
(SD ¼ 3.9; median ¼ 21.55; range: 17.3–35.4). Out of the total
sample, 30.67% of the women declared to be smokers, 27.84%
declared to havehad at least one previous pregnancy; 80.36% of
the women declared that they presented with symptoms of
endometriosis. In 334 women, a histological analysis was
performed to classify the stage of the disease (►Table 1).
The VASwas administered to evaluate the pain associated
with the ﬁve most frequent symptoms associated to endo-
metriosis (►Table 2).
Dysmenorrhea was associated with the highest percep-
tion of pain (mean VAS score of 5.76).
Impact of Single Independent Variables on Pain
The impact of independent variables on pain is described
in ►Table 3.
Stage – The logistic regression showed that the stage of
endometriosis could inﬂuence the pain associated to dys-
chezia (OR [odds ratio] ¼ 1.64; p < 0.01), and to dysuria
(OR ¼ 2.03; p ¼ 0.03). The multiple regression, which in-
cluded age among the independent variables, showed that
the ORs were 1.83 for dyschezia, and 2.30 for dysuria.
Age–Thelinear regression showed that age could inﬂuence
the pain associated to dyschezia (p < 0.01; R2 ¼ 0.03; β¼ -
0.04), to dyspareunia (p < 0.01; R2 ¼ 0.02; β ¼ - 0.06), and
to dysmenorrhea (p ¼ 0.02; R2 ¼ 0.01; β ¼-0.04).
Other variables – The logistic regression showed that
smoking habit did not inﬂuence the VAS scores (p > 0.05
for all symptoms). Similarly, the linear regression showed
that BMI did not inﬂuence the VAS scores (p > 0.05 for all
symptoms).
Finally, we have tried to understand if there could be an
association between dysmenorrhea (chosen as the reference
variable because of its greater pain score) and the other symp-
toms, using a multiple linear regression model (►Tables 4
and 5).
Dysmenorrhea is strictly associated with CCP and dyspar-
eunia, but adding ageasan independent variable, itwasstrictly
associated only with CPP. Completing the analysis with the
Spearman correlation test (►Table 6), it was possible to show
thatdysmenorrheaandCPParepositivelycorrelated (p < 0.01;
Spearman correlation coefﬁcient [Rho] ¼ 0.20); a positive
correlation could also be found between dysmenorrhea and
dyspareunia (p < 0.01; Rho ¼ 0.15). Moreover, dyschezia and
dysuria are positively correlated (p < 0.01; Rho ¼ 0.18).
Discussion
Endometriosis is a complex disease, and pain is an important
component of the syndrome, but not the only one.14 There is
increasing evidence that endometriosis elicits changes in the
population of uterine nociceptors. For example, womenwith
endometriosis havemany small unmyelinated nerveﬁbers in
the functional layer of their endometrium. These nerveﬁbers
Table 1 Stage of endometriosis
Stage Percentage (%)
I 25.45
II 32.34
III 18.56
IV 23.65
Table 2 Visual analogue scale scores (means, standard deviation
and medians) of each symptom
Symptom Mean
score
Standard
deviation
Median score
Dyschezia 1.19 2.43 0 (range 0–8)
Dysuria 0.19 1.20 0 (range 0–8)
Chronic
pelvic pain
2.55 3.52 0 (range 0–10)
Dyspareunia 2.87 3.80 0 (range 0–10)
Dysmenorrhea 5.76 3.67 7 (range 0–10)
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are probably nociceptors, and are not present in women
without endometriosis.15
Previous studies have shown that there is not an optimal
scale to evaluate (and therefore treat) pain related to endo-
metriosis, as pain is a complex and subjective domain. The
VAS seems to be the scale with a better balance between
strong and weak points.4
In the present study, dysmenorrhea was the symptom
with the highest VAS score. Previous studies have shown a
causal association between severe dysmenorrhea and endo-
metriosis, and this association seems to be independent of
the macroscopic type of the lesions or of their anatomical
locations, and may be related to recurrent cyclic micro-
bleeding in the implants. Endometriosis-related adhesions
may also cause severe dysmenorrhea.16 Moreover, the pres-
ence of a rectal or vaginal inﬁltration by posterior deep
inﬁltrating endometriosis (DIE), as well as the extensiveness
of adnexal adhesions, are the only factors strictly related to
the severity of dysmenorrhea.17
As for CPP, it could be considered nowadays a notable
health problem that challenges physicians all over theworld.
This is due to its etiology, which is still unclear, and to the
disease itself, which could have a very different presentation
(in terms of time onset and severity) among different
patients, and the response to treatments is not always
successful.18 Among the women who underwent laparosco-
py for CPP, endometriosis is found in about one third of the
cases.19
In particular, DIE is the only macroscopic type of endo-
metriosis for which the relationship with CPP symptoms
appears to be well understood.16 A prompt identiﬁcation of
the lesions, as well as of their localization, is essential for an
appropriate decision regarding the management strategy,
patient counseling, and preoperative preparation.20
In severe pelvic endometriosis, the involvement of the
urinary tract is quite common, with subsequent dysuria.
Dyschezia, on the other hand, could be considered as a useful
predictor for posterior DIE, whose severity is related to the
involvement of the posterior vaginal wall, of the rectovaginal
septum, and of anterior rectal wall DIE.17,20
Table 4 Results of the multiple linear regression
Symptom Coefficient (95% CI) p-value
Dyschezia 0.12 (0.02–0.28) 0.09
Dysuria 0.05 (0.24–0.35) 0.71
Chronic pelvic pain 0.19 (0.08–0.29) < 0.01
Dyspareunia 0.10 (0.01–0.20) 0.031
Abbreviations: CI, conﬁdence interval. Adjusted R2 0.06.
Table 5 Results of themultiple linear regression (including age
among independent variables)
Variable Coefficient (95% CI) p-value
Age 0.03 (0.07–0.01) 0.14
Dyschezia 0.11 (0.04–0.27) 0.14
Dysuria 0.04 (0.26–0.34) 0.78
Chronic Pelvic Pain 0.19 (0.08–0.29) < 0.01
Dyspareunia 0.09 (0.01–0.18) 0.06
Abbreviations: CI, conﬁdence interval. Adjusted R2 0.06.
Table 3 Impact of single independent variables on visual
analogue scale scores of each symptom
I – Impact of BMI
Symptom Coefficient Adjusted R2 p-value
Dyschezia 0.02 0.0008 0.406
Dysuria 0.008 0.0017 0.567
Chronic pelvic pain 0.002 0.0026 0.949
Dyspareunia 0.012 0.0024 0.803
Dysmenorrhea 0.073 0.0037 0.120
II – Impact of smoking habit
Symptom OR Pseudo R2 p-value
Dyschezia 0.807 0.0015 0.442
Dysuria 1.301 0.0017 0.679
Chronic pelvic pain 0.795 0.0019 0.320
Dyspareunia 1.384 0.0041 0.146
Dysmenorrhea 0.657 0.0065 0.096
III – Impact of stage
Symptom OR Pseudo R2 p-value
Dyschezia 1.641 0.0471 0.000
Dysuria 2.030 0.0602 0.030
Chronic pelvic pain 1.126 0.0031 0.239
Dyspareunia 1.073 0.0011 0.483
Dysmenorrhea 0.984 0.0000 0.897
IV – Impact of age
Symptom Coefﬁcient Adjusted R2 p-value
Dyschezia 0.048 0.0298 0.000
Dysuria 0.012 0.0063 0.066
Chronic pelvic pain 0.015 0.0011 0.448
Dyspareunia 0.062 0.0197 0.004
Dysmenorrhea 0.046 0.0105 0.025
Abbreviations: BMI, body mass index.
Table 6 Correlation matrix among the study variables
(dysmenorrhea as reference variable)
Spearman Rho p-value
Dyschezia 0.1248 0.0139
Dysuria 0.0894 0.0786
Chronic Pelvic Pain 0.2019 0.0001
Dyspareunia 0.1506 0.0030
Abbreviations: Rho, Spearman correlation coefﬁcient.
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In the present research, the logistic regression showed the
inﬂuence of the stage of endometriosis on dyschezia and on
dysuria. This is an interesting result because, in previous
studies, authors found no association between the type of
painand thestageof thedisease.21Theystated that the lackofa
consistent or strong association between pain and the stage of
the disease may be due to the hypothesis that the intensity of
the pain is most likely determined by the interaction between
endometriotic lesions and sensoryafferent nerveﬁbers, rather
than simply by the type and extent of implants alone.22 Our
results seem to challenge these previous ﬁndings.
As for the age variable, other studies showed that endome-
triosis is more frequent among young women.23 Endometri-
osis, in fact, is a disease that affects almost exclusively women
of reproductive age. In fact, its symptomsare strongly linked to
the menstrual cycle, a period in which the endometriotic
tissue (located outside the endometrium) bleeds, causing
swelling and inﬂammations.
Other studies in the literature demonstrated that the pain
caused by endometriosis has been shown to reduce sexual
satisfaction and may also lead to a signiﬁcant impairment in
health-related quality of life (QOL) when compared with the
general population.14 The QOL is very important from the
point of view of the patient: for this reason, several studies
have been conducted to assess the effects of endometriosis on
the physical and not health-related quality of life (HRQoL) of
women showing scores similar to those reported in women
with cancer (only for the physical domain).24–28 The effects
were worse in women with severe pelvic pain and advanced
disease. Women with DIE have a signiﬁcant impairment of
sexual activity.29 We have shown that dysmenorrhea is asso-
ciated with a greater perception of pain. In these patients, the
VAS scale could be used as an evaluation of the follow-up, to
assess the impact of the medical therapy on the improvement
of the symptoms. In addition, the severity of the stage of
endometriosis, correlated with the increase in dyschezia and
dysuria, can be used as an indicator for the evaluation of a
surgical treatment of endometriosis.
Themost important limitationsof thepresentstudywere:1)
the selection bias of the sample, which couldmake the sample
non-representative and, therefore, render the results ungener-
alizable; 2) the type of the study, which did not allow for the
temporal and therefore potential causal relation between the
variables; 3) the small effect sizes that should be taken in
consideration when examining the ﬁndings (►Annex 1).
As suggested by the scientiﬁc literature, it would be
interesting to complete the present study by also analyzing
the QOL of the patient by using the validated 36-item short
form survey (SF-36) questionnaire, which, although it is not
disease speciﬁc, could be used to add further information,
allowing us tomeasure at the same time both themental and
physical health of the enrolled sample.29
Conclusion
Concluding, using a validated method, the VAS, we have
provided a picture of pain perception of women suffering
from endometriosis. We have observed that dysmenorrhea
was associated with the highest perception of pain; more-
over, it is strictly associated with CCP and dyspareunia.
Smoking habit and BMI did not inﬂuence the VAS scores.
The stage of endometriosis, contrariwise, could inﬂuence the
pain associated to dyschezia and to dysuria. The age of the
patient could inﬂuence the pain associated to dyschezia, to
dyspareunia, and to dysmenorrhea. One of the most inter-
esting results of the present study was the inﬂuence of the
stage of endometriosis on dyschezia and on dysuria, which
calls into question previous evidence.
Contributors
All of the authors contributed with the project and data
interpretation, the writing of the article, the critical
review of the intellectual content, and with the ﬁnal
approval of the version to be published.
Conﬂicts of Interest
The authors have no conﬂicts of interest to declare.
References
1 Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis:
pathogenesis and treatment. Nat Rev Endocrinol 2014;10(05):
261–275. Doi: 10.1038/nrendo.2013.255
2 Olive DL, Pritts EA. Treatment of endometriosis. N Engl J Med
2001;345(04):266–275. Doi: 10.1056/NEJM200107263450407
3 Verkauf BS. Incidence, symptoms, and signs of endometriosis in
fertile and infertile women. J Fla Med Assoc 1987;74(09):671–675
4 Bourdel N, Alves J, Pickering G, Ramilo I, Roman H, Canis M.
Systematic review of endometriosis pain assessment: how to
choose a scale? Hum Reprod Update 2015;21(01):136–152.
Doi: 10.1093/humupd/dmu046
5 ChopinN, BallesterM, Borghese B, et al. Relation between severity
of dysmenorrhea and endometrioma. Acta Obstet Gynecol Scand
2006;85(11):1375–1380. Doi: 10.1080/00016340600935490
6 Lemaire GS. More than just menstrual cramps: symptoms and
uncertainty among women with endometriosis. J Obstet Gynecol
NeonatalNurs2004;33(01):71–79.Doi:10.1177/0884217503261085
7 Signorello LB, Harlow BL, Cramer DW, Spiegelman D, Hill JA.
Epidemiologic determinants of endometriosis: a hospital-based
case-control study. Ann Epidemiol 1997;7(04):267–741. Doi: 10.
1016/S1047-2797(97)00017-3
8 Bloski T, Pierson R. Endometriosis and chronic pelvic pain:
unraveling the mystery behind this complex condition. Nurs
Womens Health 2008;12(05):382–395. Doi: 10.1111/j.1751-48
6X.2008.00362.x
9 Ozawa Y, Murakami T, Terada Y, et al. Management of the pain
associated with endometriosis: an update of the painful pro-
blems. Tohoku J Exp Med 2006;210(03):175–188
10 Butrick CW. Chronic pelvic pain: howmanysurgeries are enough?
Clin Obstet Gynecol 2007;50(02):412–424. Doi: 10.1097/GRF.0b0
13e31804b195f
11 Gerlinger C, Faustmann T, Hassall JJ, Seitz C. Treatment of endo-
metriosis in different ethnic populations: a meta-analysis of two
clinical trials. BMC Womens Health 2012;12:9. Doi: 10.1186/
1472-6874-12-9
12 Dunselman GA, Vermeulen N, Becker C, et al; European Society of
Human Reproduction and Embryology. ESHRE guideline: man-
agement of women with endometriosis. Hum Reprod 2014;29
(03):400–412. Doi: 10.1093/humrep/det457
13 Revised American Society for Reproductive Medicine classiﬁca-
tion of endometriosis: 1996. Fertil Steril 1997;67(05):817–821.
Doi: 10.1016/S0015-0282(97)81391-X
Rev Bras Ginecol Obstet Vol. 41 No. 3/2019
Variables Associated with Endometriosis-related Pain Cozzolino et al.174
14 Setälä M, Härkki P, Matomäki J, Mäkinen J, Kössi J. Sexual
functioning, quality of life and pelvic pain 12 months after
endometriosis surgery including vaginal resection. Acta Obstet
Gynecol Scand 2012;91(06):692–698. Doi: 10.1111/j.1600-0412.
2012.01394.x
15 TokushigeN,MarkhamR, Russell P, Fraser IS. High density of small
nerveﬁbres in the functional layer of the endometrium inwomen
with endometriosis. Hum Reprod 2006;21(03):782–787. Doi:
10.1093/humrep/dei368
16 Fauconnier A, Chapron C. Endometriosis and pelvic pain: epide-
miological evidence of the relationship and implications. Hum
Reprod Update 2005;11(06):595–606. Doi: 10.1093/humupd/
dmi029
17 Gabriel B, Nassif J, Trompoukis P, Barata S, Wattiez A. Prevalence
and management of urinary tract endometriosis: a clinical case
series. Urology 2011;78(06):1269–1274. Doi: 10.1016/j.urology.
2011.07.1403
18 Triolo O, Laganà AS, Sturlese E. Chronic pelvic pain in endome-
triosis: an overview. J Clin Med Res 2013;5(03):153–163. Doi:
10.4021/jocmr1288w
19 Howard FM. Endometriosis and mechanisms of pelvic pain.
J Minim Invasive Gynecol 2009;16(05):540–550. Doi: 10.1016/j.
jmig.2009.06.017
20 Seracchioli R, Mabrouk M, Guerrini M, et al. Dyschezia and
posterior deep inﬁltrating endometriosis: analysis of 360 cases.
J Minim Invasive Gynecol 2008;15(06):695–699. Doi: 10.1016/j.
jmig.2008.07.005
21 Schliep KC, Mumford SL, Peterson CM, et al. Pain typology and
incident endometriosis. Hum Reprod 2015;30(10):2427–2438.
Doi: 10.1093/humrep/dev147
22 Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Cro-
signani PG. Association between endometriosis stage, lesion type,
patient characteristics and severity of pelvic pain symptoms: a
multivariate analysis of over 1000 patients. Hum Reprod 2007;22
(01):266–271. Doi: 10.1093/humrep/del339
23 Morassutto C, Monasta L, Ricci G, Barbone F, Ronfani L. Incidence
and estimated prevalence of endometriosis and adenomyosis in
Northeast Italy: a data linkage study. PLoS One 2016;11(04):
e0154227. Doi: 10.1371/journal.pone.0154227
24 NnoahamKE,Hummelshoj L,Webster P, et al;World Endometriosis
Research Foundation Global Study of Women’s Health consortium.
Impact of endometriosis on quality of life and work productivity: a
multicenter study across ten countries. Fertil Steril 2011;96(02):
366–373.e8. Doi: 10.1016/j.fertnstert.2011.05.090
25 Messina G, Quercioli C, Troiano G, et al. Italian medical students
quality of life: years 2005–2015. Ann Ig 2016;28:245–251. Doi:
10.7416/ai.2016.2103
26 Nante N, Gialluca L, De Corso M, Troiano G, Verzuri A, Messina G.
Quality of life in refugees and asylum seekers in Italy: a pilot
study. Ann Ist Super Sanita 2016;52(03):424–427. Doi: 10.4415/
ANN_16_03_14
27 Levorato S, Bocci G, Troiano G, Messina G, Nante N. Health status
of homeless persons: a pilot study in the Padua municipal dorm.
Ann Ig 2017;29(01):54–62. Doi: 10.7416/ai.2017.2132
28 Surtees PG, Wainwright NW, Khaw KT, Day NE. Functional health
status, chronic medical conditions and disorders of mood. Br J
Psychiatry 2003;183:299–303. Doi: 10.1192/bjp.183.4.299
29 Cozzolino M, Magro-Malosso ER, Tofani L, Coccia ME. Evaluation of
sexual function inwomenwithdeep inﬁltratingendometriosis. Sex
Reprod Healthc 2018;16:6–9. Doi: 10.1016/j.srhc.2017.12.005
Annex 1 Deﬁnition of symptom
Constipation Constipation is described as a common complication determined by difﬁcult and/or rare
passage of stool or both
Chronic pelvic pain Deﬁned as a noncyclical pain lasting for > 6 months that can lead to lower physical
performance and quality of life in women
Dyspareunia Dyspareunia is recurrent or persistent pain during sexual activity that causes marked
distress or interpersonal conﬂict
Dysmenorrhea Dysmenorrhea is deﬁned as recurrent common menstrual cramps. Pain usually begins 1 or 2 days
before, or when menstrual bleeding starts, and is felt in the lower abdomen, back, or thighs
Dysuria Dysuria is a symptom of pain, discomfort, or burning when urinating
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